INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)
CUSIP: 45773H409
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 66,777,963
- Total 13F shares
- 13,600,161
- Share change
- +197,486
- Total reported value
- $22,159,691
- Put/Call ratio
- 278%
- Price per share
- $1.63
- Number of holders
- 105
- Value change
- +$51,992
- Number of buys
- 49
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45773H409:
Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
9.2%
|
3,633,333
|
$6,794,333 | $0 | 31 Dec 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.7%
|
3,119,162
|
$5,708,066 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.9%
|
1,908,511
|
$3,492,575 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
1,673,588
|
$3,062,666 | — | 31 Dec 2024 | |
| Stonepine Capital Management, LLC |
13D/G
13F
|
Company |
3.8%
|
1,434,997
|
$2,683,444 | -$900,721 | 31 Mar 2025 | |
| Jong Joseph Kim |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
3,113,086
mixed-class rows
|
$2,451,149 | — | 11 Mar 2022 | |
| AIGH Capital Management LLC |
13F
|
Company |
0.98%
|
654,115
|
$1,197,031 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.96%
|
640,987
|
$1,173,006 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.94%
|
628,505
|
$1,150,392 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.76%
|
504,308
|
$922,884 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
290,436
|
$531,498 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
242,305
|
$443,418 | — | 31 Dec 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.34%
|
225,000
|
$411,750 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.33%
|
219,057
|
$400,874 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
176,974
|
$323,863 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.2%
|
133,277
|
$243,898 | — | 31 Dec 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.19%
|
126,121
|
$230,801 | — | 31 Dec 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.15%
|
97,400
|
$178,242 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.13%
|
89,864
|
$164,451 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.12%
|
81,380
|
$148,925 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.12%
|
79,079
|
$144,636 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
71,066
|
$130,051 | — | 31 Dec 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.1%
|
65,669
|
$120,174 | — | 31 Dec 2024 | |
| Green Alpha Advisors, LLC |
13F
|
Company |
0.1%
|
65,446
|
$119,766 | — | 31 Dec 2024 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.09%
|
62,567
|
$114,498 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
61,638
|
$112,799 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.08%
|
52,230
|
$95,581 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
51,255
|
$93,797 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.07%
|
46,491
|
$85,079 | — | 31 Dec 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.07%
|
43,697
|
$79,966 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
42,171
|
$77,173 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
39,704
|
$72,658 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
39,114
|
$71,578 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
39,025
|
$71,407 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.05%
|
35,431
|
$64,839 | — | 31 Dec 2024 | |
| Prime Capital Investment Advisors, LLC |
13F
|
Company |
0.05%
|
31,290
|
$57,261 | — | 31 Dec 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.04%
|
25,793
|
$47,000 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
24,000
|
$43,920 | — | 31 Dec 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.04%
|
23,495
|
$42,996 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
21,728
|
$39,762 | — | 31 Dec 2024 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.03%
|
21,112
|
$38,635 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
20,017
|
$36,631 | — | 31 Dec 2024 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.03%
|
16,906
|
$30,938 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
16,688
|
$30,539 | — | 31 Dec 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
14,887
|
$27,243 | — | 31 Dec 2024 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.02%
|
13,502
|
$24,709 | — | 31 Dec 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
12,915
|
$23,634 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.02%
|
12,370
|
$22,637 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
12,037
|
$22,028 | — | 31 Dec 2024 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
12,007
|
$21,973 | — | 31 Dec 2024 |
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q1 2025
As of 31 Mar 2025,
INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,600,161 shares.
The largest 10 holders included
Deep Track Capital, LP, BlackRock, Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, Stonepine Capital Management, LLC, STATE STREET CORP, NORTHERN TRUST CORP, MORGAN STANLEY, and UBS Group AG.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
100
Q1 2025 holders
105
Holder diff
5
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.